Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,499 | 63 | 89.0% |
| Education | $142.02 | 1 | 8.4% |
| Gift | $42.50 | 1 | 2.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $349.25 | 15 | $0 (2024) |
| Lilly USA, LLC | $289.08 | 14 | $0 (2024) |
| Valeant Pharmaceuticals North America LLC | $242.06 | 2 | $0 (2017) |
| Medtronic MiniMed, Inc. | $195.40 | 3 | $0 (2020) |
| Abbott Laboratories | $138.55 | 7 | $0 (2024) |
| Mannkind Corporation | $84.74 | 3 | $0 (2024) |
| GlaxoSmithKline, LLC. | $82.88 | 5 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $73.35 | 5 | $0 (2024) |
| Valeritas, Inc. | $40.31 | 1 | $0 (2017) |
| Dexcom, Inc. | $36.48 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $399.07 | 20 | Mannkind Corporation ($84.74) |
| 2023 | $83.60 | 4 | Abbott Laboratories ($61.00) |
| 2022 | $359.39 | 10 | Novo Nordisk Inc ($193.63) |
| 2021 | $146.58 | 10 | Lilly USA, LLC ($68.20) |
| 2020 | $167.84 | 12 | Novo Nordisk Inc ($58.19) |
| 2019 | $102.53 | 5 | GlaxoSmithKline, LLC. ($52.46) |
| 2018 | $142.02 | 1 | Medtronic MiniMed, Inc. ($142.02) |
| 2017 | $282.37 | 3 | Valeant Pharmaceuticals North America LLC ($242.06) |
All Payment Transactions
65 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $22.78 | General |
| Category: Diabetes Care | ||||||
| 12/12/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/10/2024 | BETA BIONICS, INC. | iLet Bionic Pancreas (Device), iLet Bionic Pancreas, iLet Bionic Pancreas | Food and Beverage | In-kind items and services | $26.10 | General |
| Category: Automated insulin delivery system | ||||||
| 12/05/2024 | Ascendis Pharma Inc | — | Food and Beverage | In-kind items and services | $19.17 | General |
| 11/14/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $21.76 | General |
| Category: Endocrinology | ||||||
| 11/07/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/23/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $23.39 | General |
| Category: Endocrinology | ||||||
| 10/23/2024 | Mannkind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $18.36 | General |
| Category: DIABETES MEDICINE | ||||||
| 10/16/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: Diabetes | ||||||
| 10/09/2024 | Mannkind Corporation | AFREZZA (Drug) | Gift | In-kind items and services | $42.50 | General |
| Category: DIABETES MEDICINE | ||||||
| 09/30/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $20.82 | General |
| Category: Diabetes Care | ||||||
| 09/04/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.56 | General |
| Category: Obesity | ||||||
| 08/07/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: DIABETES | ||||||
| 08/01/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $14.72 | General |
| Category: Endocrinology | ||||||
| 07/24/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.68 | General |
| Category: Diabetes | ||||||
| 06/26/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: Diabetes | ||||||
| 05/22/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.01 | General |
| Category: Diabetes | ||||||
| 05/16/2024 | Mannkind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $23.88 | General |
| Category: DIABETES MEDICINE | ||||||
| 05/09/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $18.65 | General |
| Category: Diabetes Care | ||||||
| 04/24/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.44 | General |
| Category: Diabetes | ||||||
| 08/15/2023 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $19.26 | General |
| Category: Diabetes Care | ||||||
| 03/10/2023 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $17.73 | General |
| Category: Diabetes Care | ||||||
| 02/21/2023 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Food and Beverage | In-kind items and services | $24.01 | General |
| Category: Diabetes Care | ||||||
| 02/21/2023 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $22.60 | General |
| Category: Diabetes | ||||||
| 08/30/2022 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Obesity | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 226 | 321 | $57,677 | $16,325 |
| 2022 | 8 | 237 | 302 | $49,505 | $18,299 |
| 2021 | 9 | 265 | 282 | $26,891 | $12,795 |
| 2020 | 7 | 374 | 465 | $45,790 | $19,255 |
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 71 | 121 | $33,581 | $10,456 | 31.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 39 | 39 | $15,769 | $3,948 | 25.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 17 | 18 | $3,528 | $792.96 | 22.5% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 12 | 20 | $2,652 | $484.20 | 18.3% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 17 | 22 | $720.00 | $209.44 | 29.1% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 30 | 55 | $577.00 | $176.55 | 30.6% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2023 | 20 | 23 | $437.00 | $140.53 | 32.2% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 20 | 23 | $413.00 | $116.84 | 28.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 62 | 97 | $20,953 | $8,365 | 39.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 32 | 32 | $11,046 | $3,560 | 32.2% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 31 | 35 | $5,335 | $1,943 | 36.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 23 | 29 | $4,839 | $1,809 | 37.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 18 | 18 | $3,891 | $1,347 | 34.6% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2022 | 19 | 21 | $2,429 | $896.31 | 36.9% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 21 | 24 | $683.82 | $229.61 | 33.6% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2022 | 31 | 46 | $328.00 | $148.56 | 45.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 58 | 69 | $11,773 | $5,976 | 50.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 30 | 32 | $3,695 | $1,901 | 51.4% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 20 | 20 | $3,406 | $1,570 | 46.1% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 19 | 20 | $2,936 | $1,368 | 46.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 11 | 11 | $2,865 | $1,307 | 45.6% |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | Office | 2021 | 69 | 70 | $1,649 | $394.94 | 24.0% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 17 | 17 | $376.38 | $155.36 | 41.3% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2021 | 29 | 31 | $124.00 | $98.40 | 79.4% |
| 81003 | Automated urinalysis test | Office | 2021 | 12 | 12 | $66.72 | $24.75 | 37.1% |
About Komal Motwani
Komal Motwani is a Endocrinology, Diabetes & Metabolism healthcare provider based in Greensboro, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/24/2015. The National Provider Identifier (NPI) number assigned to this provider is 1427425669.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Komal Motwani has received a total of $1,683 in payments from pharmaceutical and medical device companies, with $399.07 received in 2024. These payments were reported across 65 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($1,499).
As a Medicare-enrolled provider, Motwani has provided services to 1,102 Medicare beneficiaries, totaling 1,370 services with total Medicare billing of $66,674. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism|Student in an Organized Health Care Education/Training Program|Endocrinology, Diabetes & Metabolism
- Location Greensboro, NC
- Active Since 08/24/2015
- Last Updated 08/23/2024
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1427425669
Products in Payments
- XIFAXAN (Drug) $242.06
- MOUNJARO (Drug) $157.71
- Saxenda (Drug) $143.44
- Ozempic (Drug) $118.38
- FREESTYLE LIBRE 3 (Device) $99.24
- TRULICITY (Drug) $86.39
- AFREZZA (Drug) $84.74
- TRELEGY ELLIPTA (Drug) $82.88
- Rybelsus (Drug) $69.87
- JARDIANCE (Drug) $57.69
- Minimed 670G System (Device) $53.38
- V-GO (Device) $40.31
- Dexcom G6 Transmitter (Medical Supply) $36.48
- BAQSIMI (Drug) $35.64
- iLet Bionic Pancreas (Device) $26.10
- FREESTYLE LIBRE (Device) $24.01
- Korlym (Drug) $23.39
- GVOKE HYPOPEN (Drug) $22.60
- Wegovy (Drug) $17.56
- TEPEZZA (Biological) $17.48
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in Greensboro
Stephen South, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $875,621
Walter Kohut, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $17,473
Dr. Ajay Kumar, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $7,072
Dr. Cristina Gherghe, Md, Phd, MD, PHD
Endocrinology, Diabetes & Metabolism — Payments: $3,307
Sudan Thapa, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $1,987
Dr. Bindubal Balan, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $1,124